# Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes

Study · id `cardio:ct-nct01528059` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01528059](<https://clinicaltrials.gov/study/NCT01528059>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01528059

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 110 participants.

## Technical summary

Registry record NCT01528059. Randomized; no masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2012-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 110 participants (planned count; ClinicalTrials.gov record NCT01528059, source copy `cardio:ctgov-nct01528059-2012-02-07`, retrieved 2026-10-26)
- Start date: 2012-02 (registry gives no type) (ClinicalTrials.gov record NCT01528059, source copy `cardio:ctgov-nct01528059-2012-02-07`, retrieved 2026-10-26)
- Primary completion: 2012-02 (anticipated) (ClinicalTrials.gov record NCT01528059, source copy `cardio:ctgov-nct01528059-2012-02-07`, retrieved 2026-10-26)
- Completion: 2013-03 (anticipated) (ClinicalTrials.gov record NCT01528059, source copy `cardio:ctgov-nct01528059-2012-02-07`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01528059, source copy `cardio:ctgov-nct01528059-2012-02-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01528059-2012-02-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes
- Condition: Gastric Cancer
- Condition: Type 2 Diabetes
- Intervention (Procedure): Stomach-small intestine reconstruction
- Lead sponsor: feng Zheng
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: 8f72799d0f4bf88f8a757eb8ef4006e5aea1eaf4f8bcbc78cdde5203eb2261a2
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
